On December 23, 2024, Singular Genomics announced that Deerfield had signed a definitive agreement to acquire all of the outstanding shares of Singular Genomics common stock not currently owned by ...

We are on the cusp of reimagining healthcare, with AI, wearables, multimodal data, AR/VR, and other innovations rapidly ...

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and ...

Sex hormones have a profound impact on the brain, affecting disorders like stroke, epilepsy, and Alzheimer’s. A new review ...

In response to Trump science policies, universities are accepting fewer graduate students than normal and freezing positions, ...

NAYA Biosciences (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women’s health, today ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill University's Department of Neurology and Neurosurgery maps out the ...

How does the public feel about breakthrough technologies like AI, cell and gene therapy, cultivated meat, and new genomic ...

A comprehensive review published in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill ...

Large language models (LLMs) like OpenAI’s ChatGPT have already demonstrated remarkable proficiency in handling textual data, ...